Nasdaq:US$17.48 (+0.04) | HKEX:HK$27.38 (-0.22) | AIM:£2.54 (+0.07)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate